Kirk Tanner

Kirk Tanner" alt="Kirk Tanner" itemprop="image">

Company: National Brain Tumor Society

Job title: Chief Scientific Officer

Seminars:

Detailing the Opportunities for Epigenetic Drug Discovery & Development in CNS Tumors to Inform Pipeline Decision Making 1:45 pm

Glioblastoma is one of the first tumors where a single epigenetic modification, the methylation of the MGMT gene, was found to be of clinical relevance Cataloguing the additional alterations (IDH1/2 mutations and histone 3 variants) that either interfere with epigenetic modifier enzymes or alter alter global H3K27me3 levels Overviewing the landscape of opportunities for therapeutic…Read more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.